← Evidence map

ArticleBlood advances2021

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition.

Thomas E Lew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

45 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34478505